Get startedLog in
    Picture of Fennec Pharmaceuticals logo

    FENC — Fennec Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    All News

    Brief: Fennec Pharmaceuticals Announces European Commission Marketing Authorization For Pedmarqsi

    Picture of Fennec Pharmaceuticals logoFennec Pharmaceuticals
    06/06/2023 10:45
    June 6 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES EUROPEAN COMMISSION
MARKETING
AUTHORIZATION FOR PEDMARQSI (SODIUM THIOSULFATE) TO REDUCE THE
RISK OF HEARING LOSS IN PEDIATRIC ONCOLOGY PATIENTS

Source text for Eikon:  ID:nGNX6P11bK 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Fennec Pharmaceuticals

    See all news